Alkeon Capital Management LLC Applied Therapeutics Inc. Transaction History

Alkeon Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.77 - $18.29 $5.61 Million - $11.7 Million	-639,458 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$13.54 - $22.06 $5.44 Million - $8.87 Million	-401,876 Reduced 38.59%	639,458 $10.6 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $28.65 $5 Million - $8.65 Million	301,781 Added 40.81%	1,041,334 $19.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.44 - $24.23 $23,376 - $36,684	1,514 Added 0.21%	739,553 $16.3 Million
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $2.94 Million - $5.12 Million	100,000 Added 15.67%	738,039 $26.7 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $3.87 Million - $11 Million	198,000 Added 45.0%	638,039 $20.9 Million
Q4 2019 Feb 14, 2020	BUY	$10.16 - $28.14 $414,528 - $1.15 Million	40,800 Added 10.22%	440,039 $12 Million
Q3 2019 Nov 14, 2019	SELL	$8.08 - $10.99 $6,148 - $8,363	-761 Reduced 0.19%	399,239 $4.39 Million
Q2 2019 Aug 14, 2019	BUY	$8.1 - $10.05 $3.24 Million - $4.02 Million	400,000 New	400,000 $3.3 Million

103M

176K

165K

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $28.8M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.